FDA Inspection 1101348 — Kindos Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Kindos Pharmaceuticals Co., Ltd. on July 30, 2019 in Chengdu. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chengdu (China)